Instant

Regulatory panel clears Serum Institute’s vaccine candidate ‘Covishield’ for emergency use

Regulatory panel clears Serum Institute’s vaccine candidate ‘Covishield’ for emergency use

Subject Expert Committee (SEC) granted Emergency Use Authorization (EUA) for Covishield

A final application will be sent to DCGI before the rollout

Bharat Biotech developed the vaccine in collaboration with ICMR

A national expert panel has suggested vaccinating 30 crore people in the first half of 2021

Leave a Reply

Back to top button